At a glance
ClinicalIndex Comparison RecordN/ACompleted· 50 enrolled
Drug / intervention
Labetalol +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Comparison of Oral Nifedipine to Oral Labetolol for the Management of Severe Postpartum Hypertension
In Brief
A clinical study evaluating Labetalol and Nifedipine for Severe Postpartum Hypertension. Completed, enrolled 50 participants across 1 site.
Detailed Summary
This study's aim is to determine whether oral extended release nifedipine is superior to oral labetolol for the management of postpartum severe hypertension, specifically time to achieve goal blood pressure, and shortening hospital stay. Our hypothesis is that oral extended release nifedipine is superior to oral labetolol for achieving goal blood pressure in the postpartum period.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSevere Postpartum Hypertension
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201520162017201820192020202120222023202420252026
Enrollment StartJun 2014
First PostedJun 2014
Primary CompletionJun 2015
Study CompletionMay 2016
TodayJul 2026
First PostedJun 20, 2014
Enrollment StartJun 1, 2014
Primary CompletionJun 1, 2015
Study CompletionMay 1, 2016
TodayJul 2, 2026
Enrollment to primary: 1 yearPosted 12.0 years ago
Interventions
Labetaloldrug
Titrate up for blood pressure control
Nifedipinedrug
Titrate up to achieve blood pressure control